Cited by 251Cancer, Hypoxia, and MetabolismMetabolism, Diabetes, and CancerCancer, Lipids, and Metabolism

The DOI matches its Crossref record; 44 of the 45 references it cites were found in a registry or an index.

Hypoxia-Inducible Factor-1α and the Glycolytic Phenotype in Tumors

Open access

Robey, Ian F., Lien, Anthony D., Welsh, Sarah J., Baggett, Brenda K., Gillies, Robert J.·2005·Neoplasia

Open this paper in CoChat — free account Open PDF

Abstract

Metastatic tumors generally exhibit aerobic glycolysis (the Warburg effect). The advent of [18F]fluorodeoxyglucose positron emission tomography imaging, coupled with recent findings linking hypoxia-inducible factor (HIF-1alpha) overexpression to aggressive cancers, has rekindled an interest in this aspect of tumor metabolism. These studies explore the role of HIF-1alpha in human breast cancer lines and its relationship to glycolytic regulation. Here we demonstrate that, under normal oxygen conditions, nonmetastatic cells consume less glucose and express low HIF-1alpha, whereas metastatic cells constitutively express high glycolysis and HIF-1alpha, suggesting that dysregulation of HIF-1alpha may induce the Warburg effect. This hypothesis was tested by renormalizing HIF-1alpha levels in renal carcinoma cells, leading to inhibition of aerobic glycolysis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1593/neo.04430

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A new mathematical model for relative quantification in real-time RT-PCR
Pfaffl, M. W. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.9.e45 · Cited by 34,610
On the origin of cancer cells
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma
Weidner, N., Semple, J. P., Welch, W. R., & Folkman, J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101033240101 · Cited by 5,598
Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O 2 -Regulated Prolyl Hydroxylation
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S. N., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,836
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735 · cited 1×
“HIF-1a is constitutively expressed and destabilized in the presence of O2 by proline hydroxylation and is targeted for proteosomal degradation by the von Hippel-Lindau (vH-L) ubiquitin ligase [11–15].”
Background
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
Forsythe, J. A., Jiang, B.-H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., & Semenza, G. L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4604 · Cited by 3,981
A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation
Semenza, G. L., & Wang, G. L. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.12.5447 · Cited by 2,617
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502

Flagged first, then by citations

Show all 45 references

1 of the 45 references couldn’t be matched to a known paper.

Sorted by citations

Items 101–200 of 251

Latent Factor Analysis to Discover Pathway-Associated Putative Segmental Aneuploidies in Human Cancers
Lucas, J. E., Kung, H., & Chi, J. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000920 · Cited by 48
Melatonin and Pathological Cell Interactions: Mitochondrial Glucose Processing in Cancer Cells
Reiter, R. J., Sharma, R., Rosales‐Corral, S., Manucha, W. A., Chuffa, L. G. D. A., & Zuccari, D. A. P. D. C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212494 · Cited by 50
Targeting Metabolism to Control Immune Responses in Cancer and Improve Checkpoint Blockade Immunotherapy
Luby, A., & Alves‐Guerra, M. (2021) · Cancers · doi:10.3390/cancers13235912 · Cited by 49
Metabolic reprogramming in type 2 diabetes and the development of breast cancer
Martin, S. D., & McGee, S. L. (2018) · Journal of Endocrinology · doi:10.1530/joe-18-0037 · Cited by 47
Adipose tissue dysfunction and its effects on tumor metabolism
Diedrich, J. D., Chkourko, H., & Podgorski, I. (2015) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2014-0045 · Cited by 47
Aldolase A as a prognostic factor and mediator of progression via inducing epithelial–mesenchymal transition in gastric cancer
Jiang, Z., Wang, X., Li, J., Yang, H., & Lin, X. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13732 · Cited by 46
Sulforaphane Inhibits Nonmuscle Invasive Bladder Cancer Cells Proliferation through Suppression of HIF-1α-Mediated Glycolysis in Hypoxia
Xia, Y., Kang, T. W., Jung, Y. D., Zhang, C., & Lian, S. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b03027 · Cited by 46
Prospects for clinical cancer metabolomics using stable isotope tracers
Lane, A. N., Fan, T. W. ‐., Higashi, R. M., Tan, J., Bousamra, M., & Miller, D. M. (2009) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2009.01.005 · Cited by 46
Metabolic Cancer Biology: Structural-based analysis of cancer as a metabolic disease, new sights and opportunities for disease treatment
Masoudi‐Nejad, A., & Asgari, Y. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.01.007 · Cited by 45
Targeting lactate production and efflux in prostate cancer
Pereira‐Nunes, A., Simoes‐Sousa, S., Pinheiro, C. M., Miranda‐Gonçalves, V., Granja, S., & Baltazar, F. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165894 · Cited by 43
Molecular imaging of angiogenesis
Neeman, M., Gilad, A. A., Dafni, H., & Cohen, B. (2006) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.20774 · Cited by 43
The HIF-pathway inhibitor NSC-134754 induces metabolic changes and anti-tumour activity while maintaining vascular function
Baker, L. C. J., Boult, J. K. R., Walker‐Samuel, S., Chung, Y.-L., Jamin, Y., Ashcroft, M. A., & Robinson, S. P. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.131 · Cited by 46
Multi-tracer small animal PET imaging of the tumour response to the novel pan-Erb-B inhibitor CI-1033
Dorow, D. S., Cullinane, C. M., Conus, N. M., Roselt, P. D., Binns, D., McCarthy, T. J., McArthur, G. A., & Hicks, R. J. (2006) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-0039-5 · Cited by 42
Diabetic complications and prospective immunotherapy
Reynolds, L., Luo, Z., & Singh, K. N. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1219598 · Cited by 46
Cell-seeded polyurethane-fibrin structures – A possible system for intervertebral disc regeneration
Mauth, C., Bono, E., Shokier, H. A. A., Paesold, G., Wiese, H., Maier, G., Boos, N., & Graf‐Hausner, U. (2009) · European Cells and Materials · doi:10.22203/ecm.v018a03 · Cited by 41
Is Higher Lactate an Indicator of Tumor Metastatic Risk? A Pilot MRS Study Using Hyperpolarized 13C-Pyruvate
Xu, H. N., Kadlececk, S., Profka, H., Glickson, J. D., Rizi, R. R., & Li, L. Z. (2014) · Academic Radiology · doi:10.1016/j.acra.2013.11.014 · Cited by 41
Tumor stroma interaction is mediated by monocarboxylate metabolism
Patel, B. B., Ackerstaff, E., Serganova, I. S., Kerrigan, J. E., Blasberg, R. G., Koutcher, J. A., & Banerjee, D. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.01.013 · Cited by 42
Paclitaxel resistance development is associated with biphasic changes in reactive oxygen species, mitochondrial membrane potential and autophagy with elevated energy production capacity in lung cancer cells: A chronological study
Datta, S., Choudhury, D., Das, A. K., Mukherjee, D. D., Das, N., Roy, S. S., & Chakrabarti, G. (2017) · Tumor Biology · doi:10.1177/1010428317694314 · Cited by 40
Intratumor lactate levels reflect HER2 addiction status in HER2‐positive breast cancer
Castagnoli, L., Iorio, E., Dugo, M., Koschorke, A., Faraci, S., Canese, R., Casalini, P., Nanni, P., Vernieri, C., Nicola, M. D., et al. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27049 · Cited by 39
Linking metabolism and epigenetic regulation in development of hepatocellular carcinoma
Puszyk, W. M., Trinh, T. L., Chapple, S. J., & Liu, C. (2013) · Laboratory Investigation · doi:10.1038/labinvest.2013.94 · Cited by 38
Curbing cancer's sweet tooth: Is there a role for MnSOD in regulation of the Warburg effect?
Holley, A. K., Dhar, S. K., & Clair, D. K. S. (2012) · Mitochondrion · doi:10.1016/j.mito.2012.07.104 · Cited by 39
Role of Runx2 in IGF-1Rβ/Akt- and AMPK/Erk-dependent growth, survival and sensitivity towards metformin in breast cancer bone metastasis
Tandon, M., Chen, Z., Othman, A. H., & Pratap, J. (2016) · Oncogene · doi:10.1038/onc.2015.518 · Cited by 41
Casiopeina II-gly and bromo-pyruvate inhibition of tumor hexokinase, glycolysis, and oxidative phosphorylation
Marín‐Hernández, Á., Gallardo‐Pérez, J. C., López‐Ramírez, S. Y., García-García, J. D., Rodríguez‐Zavala, J. S., Ruíz-Azuara, L., Gracia‐Mora, I., Zentella‐Dehesa, A., Sosa‐Garrocho, M., Macías‐Silva, M., et al. (2012) · Archives of Toxicology · doi:10.1007/s00204-012-0809-3 · Cited by 36
Hypoxia-regulated microRNAs: the molecular drivers of tumor progression
Sawai, S., Wong, P., & Ramasamy, T. S. (2022) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2022.2088684 · Cited by 34
UGCG influences glutamine metabolism of breast cancer cells
Schömel, N., Hancock, S. E., Gruber, L., Olzomer, E. M., Byrne, F. L., Shah, D. P., Hoehn, K. L., Turner, N. A., Grösch, S., Geißlinger, G., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-52169-7 · Cited by 35
G6PD activation in TNBC cells induces macrophage recruitment and M2 polarization to promote tumor progression
Li, Y., Han, X., Lin, Z., Wang, C., Fu, Z., Sun, Q., & Li, C. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04810-y · Cited by 34
Immune checkpoint inhibitors in metastatic melanoma therapy (Review)
Shah, V., Panchal, V. S., Shah, A., Vyas, B., Agrawal, S. P., & Bharadwaj, S. P. (2024) · Medicine International · doi:10.3892/mi.2024.137 · Cited by 37
Metabolic dysregulation in Huntington's disease: Neuronal and glial perspectives
Chang, C., Wu, C.-W., & Chern, Y. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106672 · Cited by 37
Dietary fat without body weight gain increases in vivo MCF‐7 human breast cancer cell growth and decreases natural killer cell cytotoxicity
Lamas, B., Nachat, R., Gonçalves-Mendes, N., Mishellany, F., Rossary, A., Vasson, M., & Farges, M. (2013) · Molecular Carcinogenesis · doi:10.1002/mc.22074 · Cited by 34
Deciphering the molecular basis of breast cancer metastasis with mouse models
Vernon, A. E., Bakewell, S. J., & Chodosh, L. A. (2007) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-007-9041-5 · Cited by 34
Role of malate dehydrogenase in facilitating lactate dehydrogenase to support the glycolysis pathway in tumors
Mansouri, S., Shahriari, A., Kalantar, H., Zanjani, T. M., & Karamallah, M. H. (2017) · Biomedical Reports · doi:10.3892/br.2017.873 · Cited by 34
Non-Invasive, Simultaneous Quantification of Vascular Oxygenation and Glucose Uptake in Tissue
Rajaram, N., Reesor, A. F., Mulvey, C. S., Frees, A. E., & Ramanujam, N. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117132 · Cited by 33
Xanthohumol suppresses glioblastoma via modulation of Hexokinase 2 -mediated glycolysis
Yuan, J., Peng, G., Xiao, G., Yang, Z., Huang, J., Liu, Q., Yang, Z., & Liu, D. (2020) · Journal of Cancer · doi:10.7150/jca.33045 · Cited by 33
Wortmannin influences hypoxia-inducible factor-1 alpha expression and glycolysis in esophageal carcinoma cells
Zeng, L., Zhou, H.-Y., Tang, N., Zhang, W., He, G., Bo, H., Feng, Y., & Zhu, H. Y. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i20.4868 · Cited by 30
High expression of PKM2 as a poor prognosis indicator is associated with radiation resistance in cervical cancer.
Zhao, Y., Shen, L., Chen, X., Qian, Y., Zhou, Q., Wang, Y. X., Li, K., Liu, M., Zhang, S., & Huang, X. (2015) · PubMed · doi:10.14670/hh-11-627 · Cited by 29
Therapeutic Targeting of Cancer Cell Metabolism: Role of Metabolic Enzymes, Oncogenes and Tumor Suppressor Genes
Majeed, R., & Hamid, A. (2012) · Journal of Cancer Science & Therapy · doi:10.4172/1948-5956.1000156 · Cited by 28
Hyperlipidemia and hyper glycaemia in BreastCancer Patients is related to disease stage
Raza, U., Asif, M. R., Rehman, A. B., & Sheikh, A. (2018) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.341.14841 · Cited by 28
RNA interference targeting hypoxia-inducible factor 1α via a novel multifunctional surfactant attenuates glioma growth in an intracranial mouse model
Gillespie, D. L., Aguirre, M. T., Ravichandran, S., Leishman, L. L., Berrondo, C., Gamboa, J. T., Wang, L., King, R., Wang, X., Tan, M., et al. (2014) · Journal of neurosurgery · doi:10.3171/2014.10.jns132363 · Cited by 27
Current Advancements of Plant-Derived Agents for Triple-Negative Breast Cancer Therapy through Deregulating Cancer Cell Functions and Reprogramming Tumor Microenvironment
Wu, T.-N., Chen, H.-M., & Shyur, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413571 · Cited by 29
Macrophage-Derived Extracellular Vesicles: A Promising Tool for Personalized Cancer Therapy
Barone, A., d’Avanzo, N., Cristiano, M. C., Paolino, D., & Fresta, M. (2022) · Biomedicines · doi:10.3390/biomedicines10061252 · Cited by 26
Hydrogen Peroxide Regulates the Mitochondrial Content of Uncoupling Protein 5 in Colon Cancer Cells
Santandreu, F. M., Valle, A., de Mattos, S. F., Roca, P., & Oliver, J. (2009) · Cellular Physiology and Biochemistry · doi:10.1159/000257430 · Cited by 26
Hypoxia and mesenchymal stromal cells as key drivers of initial fracture healing in an equine in vitro fracture hematoma model
Pfeiffenberger, M., Bartsch, J., Hoff, P., Ponomarev, I., Barnewitz, D., Thöne‐Reineke, C., Buttgereit, F., Gaber, T., & Lang, A. (2019) · PLoS ONE · doi:10.1371/journal.pone.0214276 · Cited by 25
Synthesis of Indomorphan Pseudo‐Natural Product Inhibitors of Glucose Transporters GLUT‐1 and ‐3
Ceballos, J., Schwalfenberg, M., Karageorgis, G., Reckzeh, E. S., Sievers, S., Ostermann, C., Pahl, A., Sellstedt, M., Nowacki, J., Corrales, M. A. C., et al. (2019) · Angewandte Chemie · doi:10.1002/ange.201909518 · Cited by 25
Secreted Human Adipose Leptin Decreases Mitochondrial Respiration in HCT116 Colon Cancer Cells
Yehuda‐Shnaidman, E., Nimri, L., Tarnovscki, T., Kirshtein, B., Rudich, A., & Schwartz, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074843 · Cited by 26
Epithelial and Mesenchymal Tumor Compartments Exhibit In Vivo Complementary Patterns of Vascular Perfusion and Glucose Metabolism
Galiè, M., Farace, P., Nanni, C., Spinelli, A. E., Nicolato, E., Boschi, F., Magnani, P., Trespidi, S., Ambrosini, V., Fanti, S., et al. (2007) · Neoplasia · doi:10.1593/neo.07541 · Cited by 25
Tumor microenvironment-initiated lipid redox cycling for efficient triple-negative breast cancer therapy
Zhou, T., Wan, X., Zhang, M., Liu, D., Huang, L., Xing, L., Wang, Y., & Jiang, H. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122205 · Cited by 24
Oxidative stress therapy for solid tumors – A proposal
McCarty, M. F., Barroso-Aranda, J., & Contreras, F. (2010) · Medical Hypotheses · doi:10.1016/j.mehy.2009.12.029 · Cited by 24
A two-phase strategy for treatment of oxidant-dependent cancers
McCarty, M. F., Barroso-Aranda, J., & Contreras, F. (2007) · Medical Hypotheses · doi:10.1016/j.mehy.2006.12.065 · Cited by 24
Expression and/or activity of the SVCT2 ascorbate transporter may be decreased in many aggressive cancers, suggesting potential utility for sodium bicarbonate and dehydroascorbic acid in cancer therapy
McCarty, M. F. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.07.023 · Cited by 22
Histone deacetylase-1 as a prognostic factor and mediator of gastric cancer progression by enhancing glycolysis
Jiang, Z., Yang, H., Zhang, X., Wang, Z., Rong, R., & Wang, X. (2018) · Human Pathology · doi:10.1016/j.humpath.2018.10.031 · Cited by 21
Cellular Respiration and Carcinogenesis
Sarangarajan, R., & Apte, S. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-435-3 · Cited by 20
Practical strategies for suppressing hypoxia-inducible factor activity in cancer therapy
McCarty, M. F., Barroso-Aranda, J., & Contreras, F. (2010) · Medical Hypotheses · doi:10.1016/j.mehy.2009.12.022 · Cited by 21
Influence of partial and complete glutamine-and glucose deprivation of breast-and cervical tumorigenic cell lines
Visagie, M. H., Mqoco, T. V., Liebenberg, L., Mathews, E. H., Mathews, G. E., & Joubert, A. M. (2015) · Cell & Bioscience · doi:10.1186/s13578-015-0030-1 · Cited by 20
Quantification of hypoxia-related gene expression as a potential approach for clinical outcome prediction in breast cancer
Guerrab, A. E., Cayre, A., Kwiatkowski, F., Privat, M., Rossignol, J.-M., Rossignol, F., Penault-Llorca, F. M., & Bignon, Y. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175960 · Cited by 19
Systems biology of cancer: moving toward the integrative study of the metabolic alterations in cancer cells
Patiño, C. E. H., Jaime-Muñoz, G., & Reséndis-Antonio, O. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2012.00481 · Cited by 20
Evolutionary Dynamics in Vascularised Tumours under Chemotherapy: Mathematical Modelling, Asymptotic Analysis and Numerical Simulations
Villa, C., Chaplain, M. A. J., & Lorenzi, T. (2020) · Vietnam Journal of Mathematics · doi:10.1007/s10013-020-00445-9 · Cited by 21
Glycolytic metabolism confers resistance to combined all-trans retinoic acid and arsenic trioxide-induced apoptosis in HL60ρ0 cells
Herst, P. M., Hesketh, E. L., Ritchie, D. S., & Berridge, M. V. (2007) · Leukemia Research · doi:10.1016/j.leukres.2007.04.014 · Cited by 20
Metabolic Rewiring in Radiation Oncology Toward Improving the Therapeutic Ratio
van Gisbergen, M. W., Zwilling, E., & Dubois, L. J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.653621 · Cited by 20
Modulation of Hypoxia-Induced Chemoresistance to Polymeric Micellar Cisplatin: The Effect of Ligand Modification of Micellar Carrier Versus Inhibition of the Mediators of Drug Resistance
Abyaneh, H. S., Soleimani, A., Vakili, M. R., Soudy, R., Kaur, K., Cuda, F., Tavassoli, A., & Lavasanifar, A. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10040196 · Cited by 19
Oncogenic functions of the FOXC2 transcription factor: a hallmarks of cancer perspective
Hargadon, K. M., Goodloe, T. B., & Lloyd, N. D. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10045-3 · Cited by 18
Warburg Effect as a Novel Mechanism for Homocysteine-Induced Features of Age-Related Macular Degeneration
Samra, Y. A., Zaidi, Y., Rajpurohit, P., Raghavan, R., Cai, L., Kaddour‐Djebbar, I., & Tawfik, A. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021071 · Cited by 18
Metabolomic Dynamic Analysis of Hypoxia in MDA-MB-231 and the Comparison with Inferred Metabolites from Transcriptomics Data
Tsai, I., Kuo, T.-C., Ho, T., Harn, Y., Wang, S., Fu, W., Kuo, C., & Tseng, Y. J. (2013) · Cancers · doi:10.3390/cancers5020491 · Cited by 18
ZnCl2 sustains the adriamycin-induced cell death inhibited by high glucose
Garufi, A., Trisciuoglio, D., Cirone, M., & D’Orazi, G. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.178 · Cited by 18
Inhibition of HIF1α and PDK Induces Cell Death of Glioblastoma Multiforme
Han, J. E., Lim, P. W., Na, C. M., Choi, Y. S., Lee, J. Y., Kim, Y., Park, H. W., Moon, H. E., Heo, M. S., Park, H. R., et al. (2017) · Experimental Neurobiology · doi:10.5607/en.2017.26.5.295 · Cited by 18
17-β Estradiol up-regulates energy metabolic pathways, cellular proliferation and tumor invasiveness in ER+ breast cancer spheroids
Pacheco-Velázquez, S. C., Ortega-Mejia, I. I., Vargas-Navarro, J. L., Padilla-Flores, J. A., Robledo‐Cadena, D. X., Tapia-Martínez, G., Castro, I. P., Aguilar-Ponce, J. L., Granados-Rivas, J. C., Moreno‐Sánchez, R., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1018137 · Cited by 16
Estimation of energy pathway fluxes in cancer cells - Beyond the Warburg effect
Moreno‐Sánchez, R., Robledo‐Cadena, D. X., Pacheco-Velázquez, S. C., Vargas-Navarro, J. L., Padilla-Flores, J. A., & Rodríguez‐Enríquez, S. (2023) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2023.109559 · Cited by 16
Oxygen-Dependent Interactions between the Ruthenium Cage and the Photoreleased Inhibitor in NAMPT-Targeted Photoactivated Chemotherapy
Abyar, S., Huang, L., Husiev, Y., Bretin, L., Chau, B., Ramu, V., Wildeman, J., Belfor, K., Wijaya, L. S., van der Noord, V. E., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00589 · Cited by 14
Reactive oxygen species-responsive theranostic nanoparticles for enhanced hypoxic tumor photodynamic therapy via synchronous HIF-1α inhibition and ATP depletion
Zhao, C., Li, Y., Shao, L., Wang, X., Lu, J., Li, X., Chen, L., Cui, X., Sheng, W., Deng, X., et al. (2019) · Materials Chemistry Frontiers · doi:10.1039/c9qm00270g · Cited by 16
Progressive increase of glucose transporter-3 (GLUT-3) expression in estrogen-induced breast carcinogenesis
Koçdor, M. A., Koçdor, H., Pereira, J. S., Vanegas, J. E., Russo, I. H., & Russo, J. (2012) · Clinical & Translational Oncology · doi:10.1007/s12094-012-0882-3 · Cited by 16
Compensatory alterations in energy homeostasis characterized in uterine tumors from hereditary leiomyomatosis and renal cell cancer
Catherino, W. H., Mayers, C. M., Mantzouris, T., Armstrong, A. Y., Linehan, W. M., & Segars, J. H. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.11.198 · Cited by 16
miR-210 Expression Is Strongly Hypoxia-Induced in Anaplastic Thyroid Cancer Cell Lines and Is Associated with Extracellular Vesicles and Argonaute-2
Powell, B. H., Turchinovich, A. A., Wang, Y., Gololobova, O. A., Buschmann, D., Zeiger, M. A., Umbricht, C. B., & Witwer, K. W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054507 · Cited by 14
Expression of Glucose Transporter-1, Hypoxia-Inducible Factor-1α, Phosphatidylinositol 3-Kinase and Protein Kinase B (Akt) in Relation to [ 18 F]Fluorodeoxyglucose Uptake in Nasopharyngeal Diffuse Large B-Cell Lymphoma: A Case Report and Literature Review
Fang, J., Luo, X.-M., Yao, H.-T., Zhou, S.-H., Ruan, L.-X., & Yan, S.-X. (2010) · Journal of International Medical Research · doi:10.1177/147323001003800632 · Cited by 14
Cellular energetics as a target for tumor cell elimination
Maximchik, P. V., Kulikov, A. V., Zhivotovsky, B., & Gogvadze, V. G. (2016) · Biochemistry (Moscow) · doi:10.1134/s0006297916020012 · Cited by 16
Tesmilifene may enhance breast cancer chemotherapy by killing a clone of aggressive, multi-drug resistant cells through its action on the p-glycoprotein pump
Vincent, M. D. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2005.11.005 · Cited by 14
The rate of aerobic glycolysis is a pivotal regulator of tumor progression
Zare, M. E., Kansestani, A. N., Hemmati, S., Mansouri, K., & Vaisi‐Raygani, A. (2021) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-021-00774-7 · Cited by 13
Extracellular vesicles derived from macrophages: Current applications and prospects in tumors
Lou, K., Feng, S., Luo, H., Zou, J., Zhang, G., & Zou, X. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1097074 · Cited by 15
Silencing of HIF-1α by RNA Interference in Human Glioma Cells In Vitro and In Vivo
Gillespie, D. L., Flynn, J. R., Ragel, B. T., Arce-Larreta, M., Kelly, D. A., Tripp, S. R., & Jensen, R. L. (2008) · Methods in molecular biology · doi:10.1007/978-1-60327-547-7_14 · Cited by 12
Breathprinting analysis and biomimetic sensor technology to detect lung cancer
Vanstraelen, S., Jones, D. R., & Rocco, G. (2023) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2023.02.029 · Cited by 11
Oxidative Phosphorylation and Cancer: The Ongoing Warburg Hypothesis
Ristow, M., & Cuezva, J. M. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-435-3_1 · Cited by 11
Metabolic Reprogramming of Breast Tumor-Educated Macrophages Revealed by NMR Metabolomics
Dias, A. S., Almeida, C. R., Helguero, L. A., & Duarte, I. F. (2023) · Cancers · doi:10.3390/cancers15041211 · Cited by 12
Remifentanil up‐regulates HIF1α expression to ameliorate hepatic ischaemia/reperfusion injury via the ZEB1/LIF axis
Zhou, R., Li, S., Mei, X., Jiang, T., & Wang, Q. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15929 · Cited by 11
HIF1α activation in dendritic cells under sterile conditions promotes an anti-inflammatory phenotype through accumulation of intracellular lipids
Wood, E. G., Macdougall, C. E., Blythe, H. C., Clément, M., Colas, R. A., Dalli, J., Marelli‐Berg, F. M., & Longhi, M. P. (2020) · Scientific Reports · doi:10.1038/s41598-020-77793-6 · Cited by 11
One-stop-shop tumor imaging: buy hypoxia, get lactate free
Manzoor, A. A., Schroeder, T., & Dewhirst, M. W. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35543 · Cited by 11
Cellular Invasion Assay for the Real-Time Tracking of Individual Cells in Spheroid or Tumor-like Mimics
Kenney, R. M., Lee, M. C., Boyce, M. W., Sitte, Z. R., & Lockett, M. R. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.2c05201 · Cited by 10
Modeling the role of HIF in the regulation of metabolic key genes LDH and PDH: Emergence of Warburg phenotype
Spinicci, K., Jacquet, P., Powathil, G., & Stéphanou, A. (2022) · Computational and Systems Oncology · doi:10.1002/cso2.1040 · Cited by 10
Multiscale modeling of tumor adaption and invasion following anti‐angiogenic therapy
Cess, C. G., & Finley, S. D. (2022) · Computational and Systems Oncology · doi:10.1002/cso2.1032 · Cited by 9
Imaging Sensitivity of Quiescent Cancer Cells to Metabolic Perturbations in Bone Marrow Spheroids
Cavnar, S. P., Xiao, A., Gibbons, A. E., Rickelmann, A. D., Neely, T., Luker, K. E., Takayama, S., & Luker, G. D. (2016) · Tomography · doi:10.18383/j.tom.2016.00157 · Cited by 10
An Observation on Enhanced Extracellular Acidification and Lactate Production Induced by Inhibition of Lactate Dehydrogenase A
Jiang, J., Roman, J., Xu, H. N., & Li, L. Z. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-48238-1_26 · Cited by 8
Sodium Thiosulphate-Loaded Liposomes Control Hydrogen Sulphide Release and Retain Its Biological Properties in Hypoxia-like Environment
Sanchez-Aranguren, L. C., Grubliauskiene, M., Shokr, H., Balakrishnan, P., Wang, K., Ahmad, S., & Marwah, M. K. (2022) · Antioxidants · doi:10.3390/antiox11112092 · Cited by 9
Immune microenvironment of the gene signature reflecting the standardised uptake value on 18F-fluorodeoxyglucose positron emission tomography/computed tomography in head and neck squamous cell carcinoma
Han, S., Oh, J. S., & Kim, J. S. (2020) · Annals of Nuclear Medicine · doi:10.1007/s12149-020-01537-9 · Cited by 8
Expression analysis of HIF-3α as a potent prognostic biomarker in various types of human cancers
Yazdani, B., & Sirous, H. (2022) · Research in Pharmaceutical Sciences · doi:10.4103/1735-5362.355210 · Cited by 8
Antitumor effect of trimetazidine in a model of solid Ehrlich carcinoma is mediated by inhibition of glycolytic pathway and AKT signaling
Hazem, R. M., Aboslema, R. F., Mehanna, E. T., Kishk, S. M., Elsayed, M. O. K., & El-Sayed, N. M. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110672 · Cited by 7
Metabolic reprogramming on breast cancer stem Cells: Proliferation and self-renewal, epithelial-mesenchymal transition (EMT), and drug resistance
Chen, F., Zhao, B., Tian, Y., Liu, Q., & Zhang, B. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152079 · Cited by 7
Osteocyte differentiation requires glucose metabolism, but mature osteocytes display metabolic flexibility
Prideaux, M., Palmier, M., Kitase, Y., Sone, Y., Bonewald, L. F., & O’Connell, T. M. (2025) · Bone · doi:10.1016/j.bone.2025.117694 · Cited by 12
Oncogenic FLT3 internal tandem duplication activates E2F1 to regulate purine metabolism in acute myeloid leukaemia
Ou, Z., Wang, K., Shen, W.-W., Deng, G., Xu, Y., Wang, L.-F., Zai, Z., Ling, Y., Zhang, T., Peng, X., et al. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115458 · Cited by 7
Electroshock therapy and multiple sclerosis.
Savitsky, N., & Karliner, W. (1951) · PubMed · Cited by 7
HypoxamiRs in pancreatic cancer: master regulators of the hypoxic tumor microenvironment
Sangani, P. S., Maharati, A., Payami, B., Aliakbarian, M., & Abbaszadegan, M. R. (2025) · Cell Biology and Toxicology · doi:10.1007/s10565-025-10092-w · Cited by 6
A reduced model of cell metabolism to revisit the glycolysis-OXPHOS relationship in the deregulated tumor microenvironment
Jacquet, P., & Stéphanou, A. (2023) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2023.111434 · Cited by 6
Emerging applications of extracellular vesicles in tumor therapy
Luo, H., Jin, J., Jin, J., Lou, K., He, H., Feng, S., Zeng, F., & Zou, J. (2023) · Cancer Nanotechnology · doi:10.1186/s12645-023-00217-3 · Cited by 6
The Warburg Effect and Beyond: Metabolic Dependencies for Cancer Cells
Hockenbery, D. M., Tom, M. F., Abikoff, C., & Margineantu, D. H. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5847-0_2 · Cited by 6

Authors: Robey, I. F., Lien, A. D., Welsh, S. J., Baggett, B. K., & Gillies, R. J.
Affiliations: University of Arizona Cancer Center (US)
Corresponding author: Gillies, Robert J.
ORCID: Robey, Ian F.
Lien, Anthony D.
Welsh, Sarah J.
Baggett, Brenda K.
Gillies, Robert J.
Venue: Neoplasia
Publisher: Elsevier BV
Published: 2005-04
Volume: 7
Issue: 4
Pages: 324-330
ISSN: 1476-5586 (ISSN-L)
DOI: 10.1593/neo.04430
PMC: PMC1501147
OpenAlex: W2088715496
Cited by: 251
References: 45
Citations by year: 2026: 6 · 2025: 8 · 2024: 9 · 2023: 16 · 2022: 14 · 2021: 15 · 2020: 10 · 2019: 16 · 2018: 7 · 2017: 8 · 2016: 6 · 2015: 10 · 2014: 15 · 2013: 14 · 2012: 9
FWCI: 5.45
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by-nc-nd
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
creativecommons.org/licenses/by-nc-nd/3.0/ (vor, 3321 d)
Locations: Neoplasia (publishedVersion, cc-by-nc-nd)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders: National Institutes of Health
National Cancer Institute (R01-CA77575, R01CA077575, R01-CA77975-05)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
Keywords: hypoxia-inducible factor-1α, aerobic glycolysis, Warburg effect, cancer metabolism, metastasis, breast cancer cell lines, renal carcinoma cells, glucose utilization, glycolytic regulation, HIF-1α overexpression
MeSH terms: Hypoxia, Glucose, Glycolysis, Humans, Lactates, Neoplasms, Phenotype, Time Factors, Transcription Factors, Blotting, Western, Gene Expression Regulation, Neoplastic, DNA Primers, Reverse Transcriptase Polymerase Chain Reaction, Cell Line, Tumor, Hypoxia-Inducible Factor 1, alpha Subunit

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Hypoxia-Inducible Factor-1α and the Glycolytic Phenotype in Tumors

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks